MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells

Oncology Reports

Volumn 28, Issue 2, 2012, Pages 701-706

  Wei, Wei ^a,b   Hu, Zheng ^a   Fu, Hanjing ^a   Tie, Yi ^a   Zhang, Haihong ^b   Wu, Yongge ^b   Zheng, Xiaofei ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Ets1; HepG2 cell; Invasion; MicroRNA; MicroRNA 1; MicroRNA 499; Migration

Indexed keywords

LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 1; MICRORNA 499; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CELL INVASION INHIBITION; CELL STRAIN HEPG2; CELLULAR PARAMETERS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ETS 1 GENE; EXTRACELLULAR MATRIX; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEIN C-ETS-1; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84863442652     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1850     Document Type: Article

References (36)

1. WHO: The global burden of disease 2004 update. World Health Organization. Geneva, (part 2) pp12-13, 2004.
2. Parkin DM, Bray F, Ferlay J and Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156, 2001. (Pubitemid 32911406)
3. London WT and McGlynn KA: Liver cancer. In: Cancer Epidemiology and Prevention. Schottenfeld D, Fraumeni JF Jr (eds). 3rd edition. Oxford University Press, New York, pp763-786, 2006.
4. Sementchenko VI and Watson DK: Ets target genes: past, present and future. Oncogene 19: 6533-6548, 2000. (Pubitemid 32108443)
5. Naito S, Shimizu S, Matsuu M, et al: Ets-1 upregulates matrix metalloproteinase-1 expression through extracellular matrix adhesion in vascular endothelial cells. Biochem Biophys Res Commun 291: 130-138, 2002. (Pubitemid 34681148)
6. Kitange G, Tsunoda K, Anda T, et al: Immunohistochemical expression of Ets-1 transcription factor and the urokinase-type plasminogen activator is correlated with the malignant and invasive potential in meningiomas. Cancer 89: 2292-2300, 2000.
7. Behrens P, Rothe M, Wellmann A, Krischler J and Wernert N: The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 194: 43-50, 2001.
8. Takanami I, Takeuchi K and Karuke M: Expression of ETS-1 is correlated with urokinase-type plasminogen activator and poor prognosis in pulmonary adenocarcinoma. Tumour Biol 22: 205-210, 2001. (Pubitemid 32588914)
9. Behrens P, Rothe M, Florin A, Wellmann A and Wernert N: Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression. Int J Mol Med 8: 149-154, 2001.
10. Nakada M, Yamashita J, Okada Y and Sato H: Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors. J Neuropathol Exp Neurol 58: 329-334, 1999. (Pubitemid 29187895)
11. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007. (Pubitemid 46890874)
12. Wurmbach E, Chen YB, Khitrov G, et al: Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 45: 938-947, 2007. (Pubitemid 46646500)
13. Lee JS and Thorgeirsson SS: Comparative and integrative functional genomics of HCC. Oncogene 25: 3801-3809, 2006.
14. Lemmer ER, Friedman SL and Llovet JM: Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling. Semin Liver Dis 26: 373-384, 2006. (Pubitemid 44632928)
15. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
16. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
17. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006. (Pubitemid 44629897)
18. Ventura A and Jacks T: MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591, 2009.
19. Kumar MS, Lu J, Mercer KL, Golub TR and Jacks T: Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677, 2007. (Pubitemid 46676103)
20. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
21. Ozen M, Creighton CJ, Ozdemir M and Ittmann M: Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27: 1788-1793, 2008. (Pubitemid 351380263)
22. Budhu A, Jia HL, Forgues M, et al: Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47: 897-907, 2008. (Pubitemid 351449681)
23. Li LM, Hu ZB, Zhou ZX, et al: Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 70: 9798-9807, 2010.
24. Zhou J, Yu L, Gao X, et al: Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 29: 4781-4788, 2011.
25. Ladeiro Y, Couchy G, Balabaud C, et al: MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47: 1955-1963, 2008. (Pubitemid 351952843)
26. Kanda K, Nakayama T, Onizuka S, Tomioka T and Kanematsu T: Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma. Hepatogastroenterology 49: 747-751, 2002.
27. Cui J, Fu H, Feng J, Zhu J, Tie Y, Xing R, Wang C and Zheng X: The construction of miRNA expression library for human. Progr Biochem Biophys 34: 389-394, 2007. (Pubitemid 47138078)
28. Nakamura T, Nishizawa T, Hagiya M, et al: Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443, 1989. (Pubitemid 19277521)
29. Calin GA, Sevignani C, Dumitru CD, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004, 2004. (Pubitemid 38327724)
30. Span PN, Manders P, Heuvel JJ, et al: Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer. Oncogene 21: 8506-8509, 2002. (Pubitemid 36054891)
31. Naito S, Shimizu K, Nakashima M, et al: Overexpression of Ets-1 transcription factor in angiosarcoma of the skin. Pathol Res Pract 196: 103-109, 2000. (Pubitemid 30095645)
32. Oda N, Abe M and Sato Y: ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3. J Cell Physiol 178: 121-132, 1999. (Pubitemid 29034855)
33. Sato Y, Abe M, Tanaka K, et al: Signal transduction and transcriptional regulation of angiogenesis. Adv Exp Med Biol 476: 109-115, 2000. (Pubitemid 32176130)
34. Jiang Y, Xu W, Lu J, He F and Yang X: Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1. Biochem Biophys Res Commun 286: 1123-1130, 2001. (Pubitemid 32924886)
35. Tamagnone L and Comoglio PM: Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors. Cytokine Growth Factor Rev 8: 129-142, 1997. (Pubitemid 27299141)
36. Paumelle R, Tulasne D, Kherrouche Z, et al: Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene 21: 2309-2319, 2002. (Pubitemid 34407290)